mTOR-inhibitor treatment of metastatic renal cell carcinoma: contribution of Choi and modified Choi criteria assessed in 2D or 3D to evaluate tumor response
Crossref DOI link: https://doi.org/10.1007/s00330-015-3828-7
Published Online: 2015-05-08
Published Print: 2016-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lamuraglia, M.
Raslan, S.
Elaidi, R.
Oudard, S.
Escudier, B.
Slimane, K.
Penna, R. Renard
Wagner, M.
Lucidarme, O.
Text and Data Mining valid from 2015-05-08